Cargando…
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity
Tuberculosis (TB) elimination is possible with the discovery of accurate biomarkers that define the stages of infection. Drug-resistant TB impair the current treatment strategies and worsen the unfavourable outcomes. The knowledge on host immune responses between drug-sensitive and drug-resistant in...
Autores principales: | Sampath, Pavithra, Rajamanickam, Anuradha, Thiruvengadam, Kannan, Natarajan, Alangudi Palaniappan, Hissar, Syed, Dhanapal, Madhavan, Thangavelu, Bharathiraja, Jayabal, Lavanya, Ramesh, Paranchi Murugesan, Ranganathan, Uma Devi, Babu, Subash, Bethunaickan, Ramalingam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842614/ https://www.ncbi.nlm.nih.gov/pubmed/36646786 http://dx.doi.org/10.1038/s41598-023-27895-8 |
Ejemplares similares
-
Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2023) -
Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2022) -
Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2023) -
Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection
por: Sampath, Pavithra, et al.
Publicado: (2018) -
Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2021)